Jiangsu Nhwa Pharmaceutical Co., Ltd.

This early-phase study tested a new drug called NH280105 in 32 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side effects and changes in lab results. This is a first step toward…

This early-phase trial tested the safety and how the body processes multiple doses of an experimental drug called NH102 in 40 healthy adults aged 18 to 45. Participants received either the drug or a placebo, and researchers monitored side effects, lab results, and vital signs. Th…